Indian equities extended losses for a fifth session amid rising oil prices, persistent FII outflows and geopolitical tensions. Investors no...

Indian stock markets experienced significant declines on Wednesday. Escalating Iran-US tensions and tariff threats spooked investors, causi...

Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...

Dalal Street ended the week on a strong note, with the Sensex and Nifty gaining over 1% on Friday. Investors will track six key market trig...

Indian stock markets saw gains on Friday, with Sensex and Nifty trading higher. IT stocks led the gains, while broader markets experienced ...

Veteran investor Rekha Jhunjhunwala sold over 1.07 crore Canara Bank shares during the April–June quarter, reducing her stake from 1.54% to...

Ace investor Rekha Jhunjhunwala has likely exited her investment in Raghav Productivity Enhancers after steadily reducing her stake over re...

Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...

Investor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...

Farmers in Andhra Pradesh's Srikakulam and Vizianagaram districts are shifting to water-saving rice farming techniques. Facing potential El...

Amidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

Sun Pharma Q4 Results: Profit after tax (PAT) fell 19% sequentially during the quarter under review from Rs 3,369 crore in Q3FY26, while re...

Sun Pharma Q1FY24 net profit fell 2% YoY to Rs 2023 crore due to exceptional items worth Rs 323 crore. However, excluding exceptional items...

Total revenue for the quarter grew 10.73 per cent YoY to Rs 10,761.76 crore compared with Rs 9,718.74 crore in the corresponding quarter la...

Sun Pharma shares traded 2.78 per cent higher at Rs 482.25 after the announcement of its quarterly results.